Savara (SVRA) Gets a Buy from LifeSci Capital
at www.tipranks.com (Sat, 21-Mar 10:55 AM)
De-Risked Path to Market and Concentrated Rare Disease Opportunity Support Buy Rating on Savara’s Molbreevi
at www.tipranks.com (Mon, 16-Mar 11:35 AM)
Analysts Are Bullish on Top Healthcare Stocks: Savara (SVRA), Erasca (ERAS)
at www.tipranks.com (Mon, 16-Mar 6:50 AM)
